Artivion, Inc.
AORT · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.21 | -0.72 | 5.30 | -0.03 |
| FCF Yield | 0.88% | -0.51% | -1.98% | 0.73% |
| EV / EBITDA | 154.36 | 97.48 | 126.02 | -2,665.84 |
| Quality | ||||
| ROIC | 1.49% | 0.42% | 0.06% | 0.36% |
| Gross Margin | 65.61% | 64.72% | 64.23% | 63.20% |
| Cash Conversion Ratio | 3.15 | 11.18 | 33.57 | -0.62 |
| Growth | ||||
| Revenue 3-Year CAGR | 7.55% | 7.21% | 6.85% | 7.38% |
| Free Cash Flow Growth | 351.61% | 65.93% | -336.30% | 11.49% |
| Safety | ||||
| Net Debt / EBITDA | -5.16 | 12.91 | 30.02 | -546.54 |
| Interest Coverage | 2.05 | 1.15 | 0.28 | 0.27 |
| Efficiency | ||||
| Inventory Turnover | 0.43 | 0.46 | 0.43 | 0.45 |
| Cash Conversion Cycle | 248.20 | 232.61 | 265.62 | 234.77 |